Skip to main content
Kindstar Globalgene Technology, Inc. logo

Kindstar Globalgene Technology, Inc. — Investor Relations & Filings

Ticker · 9960 ISIN · KYG5262E1044 HKEX Human health and social work activities
Open in API
Filings indexed 603 across all filing types
Latest filing 2022-11-28 Transaction in Own Shar…
Country HK Hong Kong
Listing HKEX 9960

About Kindstar Globalgene Technology, Inc.

http://www.kindstar.com.cn

Kindstar Globalgene Technology, Inc. is a leading independent provider of advanced specialty clinical testing services, specializing in esoteric testing. The company maintains the largest esoteric testing portfolio in its market, utilizing internationally-advanced laboratory facilities for clinical testing, scientific research, and applied R&D. Its comprehensive testing menu, featuring over 100 items, covers critical diagnostic areas including hematology, genetic diseases, gynecology, infectious diseases, neurology, and oncology. These services provide physicians and patients access to specialized diagnostics crucial for the diagnosis and treatment of major diseases.

Recent filings

Filing Released Lang Actions
Next Day Disclosure Returns
Transaction in Own Shares Classification · 95% confidence The document is titled 'Next Day Disclosure Return' and pertains to changes in issued share capital and share buybacks by Kindstar Globalgene Technology, Inc. It includes detailed tables of repurchase of shares with dates and quantities, and references to compliance with listing rules of the Stock Exchange of Hong Kong. The content is focused on reporting share repurchase activities, which aligns with announcements of transactions in own shares. There is no indication of financial statements, management discussion, or other report types. The document is not a full financial report but a regulatory disclosure of share repurchases. Therefore, the appropriate classification is 'Transaction in Own Shares' (POS). The document length and detail support a high confidence in this classification.
2022-11-28 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks for Kindstar Globalgene Technology, Inc. It includes detailed tables of repurchases of shares on various dates and confirms compliance with listing rules and legal requirements. The content focuses on share repurchase activities and changes in issued shares, which aligns with announcements regarding share buybacks or capital changes. It is not a full financial report, earnings release, or management discussion. The document is lengthy (15,000 characters) and contains substantive data on share repurchases, not merely an announcement of a report. Therefore, the appropriate classification is 'Transaction in Own Shares' (POS).
2022-11-25 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by Kindstar Globalgene Technology, Inc. It contains detailed tables of repurchase of shares with dates and quantities, and references to rules from the Stock Exchange of Hong Kong (SEHK). The content is focused on reporting share repurchase activities, not a full financial report or earnings release. This matches the description of a 'Transaction in Own Shares' filing, which reports the company's buyback of its own shares. The document is lengthy and detailed, not a brief announcement or certification, so it is not Regulatory Filings or Report Publication Announcement. Therefore, the correct classification is 'POS' for Transaction in Own Shares.
2022-11-24 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and pertains to changes in issued share capital and share buybacks by Kindstar Globalgene Technology, Inc. It details numerous repurchases of shares with dates and quantities, referencing compliance with listing rules of the Stock Exchange of Hong Kong. The content is a regulatory disclosure about share repurchases, not a financial report, earnings release, or management discussion. It is a formal notification of transactions in the company's own shares (share buybacks). Therefore, the document fits the category of 'Transaction in Own Shares' (POS). The document length and detail confirm it is not a brief announcement but a full disclosure form.
2022-11-23 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by Kindstar Globalgene Technology, Inc. It details numerous repurchases of shares with dates and quantities, confirming compliance with listing rules of the Stock Exchange of Hong Kong. The content is focused on reporting share repurchase transactions and changes in share capital, not on financial results, management commentary, or other report types. This matches the description of a 'Transaction in Own Shares' filing, which reports company buybacks or sales of its own shares. The document is substantive and detailed, not a brief announcement or certification, so it is not Regulatory Filings or Report Publication Announcement. Therefore, the correct classification is POS (Transaction in Own Shares).
2022-11-22 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 95% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by Kindstar Globalgene Technology, Inc. It contains detailed tables of repurchase of shares with dates and quantities, and references to compliance with listing rules of the Stock Exchange of Hong Kong. The content is focused on reporting share repurchase transactions and changes in share capital, which aligns with announcements of transactions in own shares. The document is not a full financial report, earnings release, or management discussion, but a regulatory disclosure of share repurchase activity. Therefore, the appropriate classification is 'Transaction in Own Shares' (POS). The document length and detail support a high confidence in this classification.
2022-11-21 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.